• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1989 Fiscal Year Final Research Report Summary

Induction of cytotoxicity of human tumor-infiltrating lymphocytes against autologous tumor cells and its application for cancer therapy

Research Project

Project/Area Number 63570599
Research Category

Grant-in-Aid for General Scientific Research (C)

Allocation TypeSingle-year Grants
Research Field General surgery
Research InstitutionOkayama University

Principal Investigator

HIZUTA Akio  Okayama University Medical School, First Department of Surgery Instructor, 医学部附属病院, 助手 (60199007)

Co-Investigator(Kenkyū-buntansha) KAMIKAWA Yasuaki  Okayama University Medical School, First Department of Surgery Assistant Profess, 医学部附属病院, 講師 (00152851)
ORITA Kunzo  Okayama University Medical School, First Department of Surgery Professor, 医学部, 教授 (20033053)
Project Period (FY) 1988 – 1989
KeywordsHuman solid cancer / Tumor-infiltrating lymphocyte / Lymphokine-activated killer (LAK) cell therapy / gammadeltaTCell / Cytotoxicity / linerleukin-2 (IL-2) / Biological response modifier (BRM) / Intratumoral injection
Research Abstract

1) Cancer patients were treated with the adoptive immunotherapy with lymphokine-activated killer (LAK) cells which were induced by culture of autologous peripheral blood lymphocytes (PBL) with interleukin-2(IL-2). Local administration by intraarterial or intracavital infusions of LAK cells produced a superior therapeutic efficacy to systemic administration by intravenous infusions.
2)A half of tumor-infiltrating cells into human solid cancers consisted of T lymphocytes and the proportion of CD8^+T lymphocytes were greater than that of PBL.Tumor-infiltrating lymphocytes (TIL) contained gammadelta T cells and the majority of those cells in colorectal cancers were CD8^+ gammadelta T cells whose lineage was different from that of PBL.Hepatocellular carcinoma contained a greater number of gammadelta TIL than other human solid cancers.
3)Culture of TIL with IL-2 alone was inadequate for their in vitro expansion, and we found that TIL effectively expanded in culture by addition of 20% conditioned medium derived from LAK cell induction.
4)Cytotoxicity against tumor cells was notdetected in freshly isolated TIL.Cytotoxicity of TIL gradually increased in culture, reached its maximum at 2 to 3 weeks, and disappeared at 4 to 7 weeks. Phytohemagglutinin (PHA) was found to be capable of partial restoration of the diminished cytotoxicity of cultured TIL.
5) TIL of advanced gastric cancer were activated in vivo by preoperative intratumoral injection with a biological response modifier, OK-432, and survival of patients after curative sugery was compared with control patients. Although there was no difference in survival of patients with scanty TIL,the activation of TIL improved 3-year survival in patients with TIL of a medium or over degree.

  • Research Products

    (24 results)

All Other

All Publications (24 results)

  • [Publications] Suo J: "Suppression of hepatic natural killer activity by liver metastasis of cancer and restoration of killer activity by oral administration of a Basidomycetes-derivpolysaccharide,PSK" Acta Medica Okayama. 48. 237-242 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Watanabe N: "Localization of T cell receptor(TCR)-γδ+T cells into colorectal cancer:flow cytometric analysis of TCR-γδ expression in tumour-infiltrating lymphocytes." Clinical and Experimental Immunology. 102. 167-173 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 折田 薫三: "LAK細胞による癌の免疫療法" Immuno-Advance. 17. 14-21 (1988)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 折田 薫三: "BRM(TNF,インターロイキンなど)" 医療ジャーナル. 25. 2207-2215 (1989)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 日伝 晶夫: "進行胃癌に対する術前免疫賦活剤腫瘍内注入療法" 消化器外科. 15. 201-209 (1992)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 日伝 晶夫: "消化器癌免疫療法" 臨床と研究. 69. 1861-1866 (1992)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 松本 三明: "腫瘍内浸潤リンパ球におけるγδT細胞の解析" 医学のあゆみ. 162. 159-160 (1992)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 日伝 晶夫: "肝転移と肝局所免疫" KARKINOS. 6. 307-313 (1993)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 渡辺 直樹: "ヒト大腸癌腫瘍浸潤リンパ球,正常部腸管リンパ球,および末梢血リンパ球のフローサイトメトリーによる分析" 消化器と免疫. 30. 195-197 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 松本 三明: "腫瘍内浸潤リンパ球のrIL-2添加培養と細胞障害活性の研究" 岡山医学会雑誌. 108. 13-29 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Hizuta A, Yunoki S, Tatemoto A, Okamoto Y, Nagata Y, et al.: "Frontiers of Mucosal Immunology" Tsuchiya M, Nagura H,Hibi T and Moro I, 2 (1991)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Hizuta A, Miyagi K, Ohno S, Tanaka N, and Orita K: "Therapeutic Plasmaapheresis(XII)" Agishi T,Kawamura A,and Mineshima M, 4 (1993)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Orita, K., and Hizuta, A.: "Cancer immunotherapy with LAK cells(in Japanese)" Immuno-Advance. 17. 14-21 (1988)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Orita, K., and Hizuta, A.: "BRM(TNF,Interleukins)(in Japanese)" Medicine and Drug Journal. 25. 2207-2215 (1989)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Hizuta, A., Gouchi, A., and Orita, K.: "Preoperative intratumor-injection therapy with immunopotentiators for advanced gastric cancer(in Japanese)" Gastroenterological Surgery. 15. 201-209 (1992)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Hizuta, S., Gouchi, A., Okabayashi, Y., Naomoto, Y., Matsuno, T., Kamikawa.Y., and Orita, K.: "Immunotherapy for gastroenterological cancers(in Japanese)" The Japanese Journal of Clinical and Experimental Medicine. 69. 1861-1866 (1992)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Matsumoto, M., Hizuta, A., Miyagi, K., Kawaguchi, H., Kataoka, K., Yamamoto, M., Naomoto, Y., Tanaka, N., and Orita, K.: "Analysis of gammadelta T cells in tumor-infiltrating lymphocytes(in Japanese with English abstract)" Journal of Clinical and Experimental Medicine(IGAKU NO AYUMI). 162. 159-160 (1992)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Hizuta, A., Takahashi, M., Watanabe, N., Iwagaki, H., Tanaka, N., and Orita, K.: "Liver metastasis and local immune responses(in Japanese)" KARKINOS. 6. 307-313 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Suo, J., Tanaka, N., Hizuta, A., Yunoki, S., and Orita, K.: "Suppression of hepatic natural killer activity by liver metastasis of cancer and restoration of killer activity by oral administration of a Basidomycetes-derived polysaccharide, PSK" Acta Medica Okayama. 48. 237-242 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Watanabe, N., Hizuta, A., Tanaka, N., and Orita, K.: "Localization of T cell receptor(TCR)-gammadelta^+T cells into colorectal cancer : flow cytometric analysis of TCR-gammadelta expression in tumour-infiltrating" Clinical and Experimental Immunology, lymphocytes. 102. 167-173 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Watanabe, N., Hizuta, A., Iwado, H., Gomi, S., Tanaka, N., and Orita, K.: "Flow cytometric analysis of tumor-infiltrating lymphocytes into human colorectal cancer, lymphocytes localized in normal intestine, and peripheral blood lymphocytes (in Japanese)" Digestive organ and Immunology. 30. 195-197 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Matsumoto, M.: "The expansion and antitumoral activity of recombinant IL-2 activated tumor-infiltrating lymphocytes from human cancers(in Japanese with English abstract)" OKAYAMA-IGAKKAI-ZASSHI. 108. 13-29 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Hizuta, A., Yunoki, S., Tatemoto, A., Okamoto, Y., Nagata, Y., Yamamoto, M., Matsumoto, M., Kawaguchi, H., Muro, M., Kataoka, K., Naomoto, Y., Tanaka, N., and Orita, K.: Enhanced therapeutic effect of lymphokine-activated killer (LAK) cells treated with neuraminidase against metastatic liver tumor in mice. In "Frontiers of Mucosal Immunology/Volume 2", eds.M.Tsuchiya, H.Nagura, T., Hibi, and I.Moro. Elservier Science Publishers B.V., Amsterdam, 507-508 (1991)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Hizuta, A., Miyagi, K., Ohno, S., Tanaka, N., and Orita, K.: Immunomodulation by pokeweed mitogen in "Therapeutic Plasmapheresis(XII)", eds.T.Agishi, A.Kawamura, and M.Mineshima. VSP,Utrecht, 651-654 (1993)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1999-03-16  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi